Page 3 - Early Feasibility Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Biosense Webster Begins Enrollment of Pivotal Trial Evaluating the Laminar Left Atrial Appendage Elimination Device

Investigational device designed for Left Atrial Appendage Elimination (LAAX) to reduce the risk of stroke in patients with non-valvular atrial fibrillation 

United statesLos roblesSaibal karJohnson medtechJennifer currinDevi nairJohnson medtechiLaminar incScientific affairsHealthcare national physicianLos robles health systemElectrophysiology divisionBernard heart vascular centerBiosense webster incCardiovascular specialty solutions at johnson medtechBiosense webster

Aria CV Announces First Patient Successfully Implanted with Second-Generation Pulmonary Hypertension System

Gen 2 System has potential to reduce cardiac workload and enhance blood flow

United statesScott hittingerAshwin ravichandranDan gladneyEarly feasibility study programAria cv incDrug administrationCardiovascular research institute in indianapolisHospital cardiovascular instituteHypertension systemCardiovascular research instituteMaria systemEarly feasibility study

CARMAT Provides Update on the Renegotiation of the Repayment Terms of Its Loans With Its Financial Creditors

CARMAT Provides Update on the Renegotiation of the Repayment Terms of Its Loans With Its Financial Creditors
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesBois darcyFrance generalCaroline carmagnolDusan oresanskyEuropean investment bankEuropean unionFrench financial markets authority autoritFood drug administrationState guaranteed loansFrench medtechEarly feasibility studyEuronext growthFrench financial markets authorityDrug administration

BiVACOR® Receives $13 Million to Support Clinical Trials for the Company s Total Artificial Heart

GOLD COAST, Australia & HUNTINGTON BEACH, Calif., February 20, 2024 BiVACOR®, a clinical-stage medical device company, today announced $13 million (USD) awarded from the Australian Government’s Medical Research Future Fund (MRFF) grant through the Artificial Heart Frontiers Program (AHFP) to support BiVACOR’s Total Artificial Heart program and future product enhancements.

New south walesUnited statesSouth australiaWilliame cohnDavid kayeDaniel timmsTexas heart instituteArtificial heart frontiers programTechnology officerMonash alfred baker centre for cardiovascular researchUniversity of new south walesAustralian government medical research future fundGriffith universityMonash universityUniversity of queenslandGrant from monash university

Breakthroughs in biotech bring us closer to better health

Breakthroughs in biotech bring us closer to better health
proactiveinvestors.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com.au Daily Mail and Mail on Sunday newspapers.

Georgia generalSanta monicaMato grosso do sulUnited statesUnited kingdomGreg hutchinsonSimon morrissDavid fosterChris meduriMichael winloPaul andersonOrthocell ltdRecce pharmaceuticalsOrd minnett healthcare forumMurdoch children research instituteIsland pharmaceuticals ltd